Granules India Limited has informed the Exchange regarding a press release dated September 25, 2020, titled "Granules India Limited announces US FDA approval of Naproxen Sodium and Diphenhydramine Hydrochloride Tablets, 220 mg/25 mg (OTC)".
Press Release Sep 25 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Granules India
Later from Granules India
- Press Release Oct 22 2020
- Press Release Dec 03 2020
- Press Release Jan 13 2021
- Press Release Feb 01 2021
- Press Release Feb 17 2021
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India